CHOLIB

This brand name is authorized in Austria, Cyprus, Estonia, Hong Kong, Croatia, Ireland, Lithuania, Poland, Singapore, United Kingdom

Active ingredients

The drug CHOLIB contains a combination of these active pharmaceutical ingredients (APIs):

1 Fenofibrate UNII U202363UOS - FENOFIBRATE

Fenofibrate is a fibric acid derivative whose lipid modifying effects reported in humans are mediated via activation of Peroxisome Proliferator Activated Receptor type α (PPARα). Through activation of PPARα, fenofibrate increases lipolysis and elimination of atherogenic triglyceride rich particles from plasma by activating lipoprotein lipase and reducing production of Apoprotein C-III. Read about Fenofibrate

2 Simvastatin UNII AGG2FN16EV - SIMVASTATIN

Simvastatin has a potent activity in inhibiting HMG-CoA reductase (3-hydroxy–3-ethylglutaryl-CoA-reductase). Simvastatin has been shown to reduce both normal and elevated LDL-C concentrations. Read about Simvastatin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
CHOLIB Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C10BA04	Simvastatin and fenofibrate	C Cardiovascular system → C10 Lipid modifying agents → C10B Lipid modifying agents, combinations → C10BA Combinations of various lipid modifying agents
Discover more medicines within C10BA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1624047, 1624058, 1624069, 1624070, 1676000, 1676011
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 321701, 321711
Country: HK	Department of Health Drug Office	Identifier(s): 66374, 66375
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1071169, 1071170, 1071171, 1071172, 1075159, 1075160
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100302695, 100302703
Country: SG	Health Sciences Authority	Identifier(s): 15664P